Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON¿ D. Santos García; N. López Ariztegui; E. Cubo; A. Vinagre Aragón; R. García-Ramos; C. Borrué; G. Fernández-Pajarín; N. Caballol; I. Cabo; J.M. Barrios-López; J. Hernández Vara; M.A. Ávila Rivera; C. Gasca-Salas; S. Escalante; P. Manrique de Lara; R. Pérez Noguera; M. Álvarez Sauco; M. Sierra; M.H.G. Monje; A. Sánchez Ferro; S. Novo Ponte; F. Alonso-Frech; D. Macías-García; I. Legarda; A. Rojo; I. Álvarez Fernández; M.T. Buongiorno; P. Pastor; P. García Ruíz;

Continuous intestinal infusion of levodopa¿carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community D. Santos-García; M.J. Catalán; V. Puente; F. Valldeoriola; I. Regidor; P. Mir; J. Matías-Arbelo; J.C. Parra; F. Grandas;

Circulating microRNAs as potential biomarkers for the diagnosis of Parkinson's disease: A meta-analysis W.T. Zhang; Y.J. Wang; Y.F. Yao; G.X. Zhang; Y.N. Zhang; S.S. Gao;